Tadpoles and tumors
A protein critical in tadpole metamorphosis has role in human cancer
Theres something magical about tadpoles. The mere mention of this little creature sparks happy memories of children screaming with delight as they splash in a shallow stream trying to capture some of the tiny swimmers in a cup. The real magic happens as the children witness the metamorphosis from tadpole to frog.
Within the mystery of this transformation is a biological series of changes that among other things, allows one appendage to be shed while four others sprout from the tadpoles body. Before a tadpole becomes a frog, it must lose its tail. A time-lapse video of this process would actually reveal that the tadpole tail doesnt simply fall off but rather grows shorter in a process called tail resorption.
Scientists who study this process on a molecular level have known that a protein called FAP (fibroblast activation protein) is involved in tail resorption. However, FAP may have a much more perverse role in humans.
“We know that FAP helps control the breakdown of the extracellular matrix that allows tadpole tail resorption, and we believe that the same type of activity has to happen for tumor growth,” said Jonathan D. Cheng, M.D., a medical oncologist and researcher at Fox Chase Cancer Center. “We are currently investigating how the two may be related biologically.
“Animal studies have shown that producing lots of FAP in the tumors microenvironment makes the cancer grow faster. We are now learning more about how FAP does that.”
In a study presented today at the 95th Annual Meeting of the American Association for Cancer Research in Orlando, Fla., Cheng and his colleagues demonstrate that the enzymatic activity of FAP is responsible for the accelerated tumor growth in mice. Chengs research also examines the ability of an antibody molecule to stop the enzymatic activity of FAP.
“We know that FAP is present in about 90 percent of human solid malignancies, so that makes this protein a target well worth pursuing,” Cheng said. “Antibodies have an inherent advantage in that they can specifically target FAP and not other proteins. Although the antibody we have studied so far has had only modest results to date, we are making some modifications to our existing antibodies to improve the molecules ability to block FAPs action. Much more research lies ahead.”
Fox Chase Cancer Center, one of the nations first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic, clinical, population and translational research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Centers web site at http://www.fccc.edu or call 1-888-FOX CHASE.
Media Contact
More Information:
http://www.fccc.eduAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Bringing bio-inspired robots to life
Nebraska researcher Eric Markvicka gets NSF CAREER Award to pursue manufacture of novel materials for soft robotics and stretchable electronics. Engineers are increasingly eager to develop robots that mimic the…
Bella moths use poison to attract mates
Scientists are closer to finding out how. Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. They’re produced by several different types of plants and are…
AI tool creates ‘synthetic’ images of cells
…for enhanced microscopy analysis. Observing individual cells through microscopes can reveal a range of important cell biological phenomena that frequently play a role in human diseases, but the process of…